Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
- Equal contributors
Arthritis Research & Therapy 2012, 14:R232 doi:10.1186/ar4075
This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.
Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.
Fields marked * are required